Loading data
TRXBNasdaq
| Unit: USD | FY2025 | FY2024 |
|---|---|---|
| Revenue | 0 USD | 39.11 m USD |
| Cost of revenue | 0 USD | 40.23 m USD |
| Gross profit | 0 USD | -1.12 m USD |
| Research and development expense | 29.81 m USD | 34.99 m USD |
| Selling, general and administrative expense | 37.63 m USD | — |
| Operating profit after depreciation | -37.85 m USD | -2.38 m USD |
| Operating profit before depreciation | -37.63 m USD | -1.12 m USD |
| EBIT | -37.85 m USD | -2.38 m USD |
| EBITDA | -37.63 m USD | -1.12 m USD |
| Interest expense | 0 USD | 0 USD |
| Profit before tax | -34.76 m USD | -444 k USD |
| Income tax expense | 46 k USD | 2.7 m USD |
| Income before extraordinary items | -34.81 m USD | -3.14 m USD |
| Net income (reported basis) | -34.81 m USD | -3.14 m USD |
| Basic EPS including extraordinary items | -33.2 USD/share | -8.92 USD/share |
| Diluted EPS including extraordinary items | -1.27 USD/share | -8.92 USD/share |
| Common dividends | 0 USD | 0 USD |
| Total dividends | 0 USD | 0 USD |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.